dc.contributor.author | Benajiba, Lina | |
dc.contributor.author | Alexe, Gabriela | |
dc.contributor.author | Su, Angela | |
dc.contributor.author | Raffoux, Emmanuel | |
dc.contributor.author | Soulier, Jean | |
dc.contributor.author | Hemann, Michael | |
dc.contributor.author | Hermine, Olivier | |
dc.contributor.author | Itzykson, Raphael | |
dc.contributor.author | Stegmaier, Kimberly | |
dc.contributor.author | Puissant, Alexandre | |
dc.date.accessioned | 2020-06-26T17:36:53Z | |
dc.date.available | 2020-06-26T17:36:53Z | |
dc.date.issued | 2018-11 | |
dc.date.submitted | 2018-08 | |
dc.identifier.issn | 0887-6924 | |
dc.identifier.issn | 1476-5551 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/126001 | |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1038/s41375-018-0291-x | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | PMC | en_US |
dc.title | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Benajiba, L. et al. "Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML." Leukemia 33, 3 (November 2018): 800–804 © 2018 Springer Nature | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.relation.journal | Leukemia | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2019-12-05T17:38:07Z | |
dspace.date.submission | 2019-12-05T17:38:09Z | |
mit.journal.volume | 33 | en_US |
mit.journal.issue | 3 | en_US |
mit.metadata.status | Complete | |